Business · 02/03/2022
FDA Announces Final Guidance for Oncology Drug Development
The FDA has released a final guidance to help oncology drug developers design and conduct first-in-human clinical trials more efficiently, aiming to expedite the development of cancer treatments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →